UK's Oncimmune Holdings slumps on lower-than-expected annual rev forecast
31/01/2025 12:51
** Shares of British immunodiagnostics developer Oncimmune
Holdings ONCON.L drop nearly 23% to 9.6 pence - a near
six-month low
** ONCON sees FY25 rev of about 4 mln pounds ($4.97 mln)
missing analysts' estimates of 6.9 mln pounds, as per LSEG data
** Adds, is discussing number of strategic collaborations
and contracts with several parties which, whilst there is no
certainty, could materially improve rev position in FY25
** Co expects FY2024 rev of about 3 mln pounds
** Stock fell ~45% in 2024
($1 = 0.8053 pounds)
(Reporting by Ankita Bora in Bengaluru)
((Ankita.Bora@thomsonreuters.com))